Navigation Links
UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
Date:5/2/2012

Houston - The University of Texas MD Anderson Cancer Center President Ronald DePinho, M.D., has been elected to the National Academy of Sciences (NAS) - one of the most prestigious accolades in the United States bestowed in the field of science and engineering.

DePinho is the first member of the MD Anderson faculty to be recognized with this distinction.

The NAS is a private, nonprofit society of distinguished scholars engaged in scientific and engineering research. Established in 1863 by President Abraham Lincoln, the NAS has served to "investigate, examine, experiment, and report upon any subject of science or art" whenever called upon to do so by any department of the government.

DePinho was elected along with 83 other members and 21 non-voting foreign associates from 15 countries. Currently, there are 2,152 active NAS members and 430 foreign associates. Nearly 200 living NAS members have won Nobel Prizes. Among the NAS's most famous members were Albert Einstein, Robert Oppenheimer, Thomas Edison, Orville Wright and Alexander Graham Bell.

"I'm thrilled beyond words," says DePinho. "It's recognition of the enormous dedication and talent of the trainees that have been in my lab. I have been incredibly fortunate to be surrounded by great people at great institutions throughout my career. Most importantly, this is an award recognizing the personal and scientific support of my wife, Dr. Lynda Chin."

DePinho was nominated by three NAS current members.

"DePinho's work on telomeres and checkpoints established that telomere attrition can have dual effects in human cancer by driving tumor suppression or enhancement, depending on genetic background," according to the academy citation. "His work also uncovered the mechanism for the increasing risk that advancing age confers on the development of the common human epithelial malignancies."

DePinho is internationally recognized for basic and translational research in cancer, aging and age-associated degenerative disorders. The range of his research includes cancer drug and biomarker development, cancer gene discovery, stem cell biology and development of genetically engineered mouse models to study cancer in humans. His laboratory has produced an array of discoveries leading to better methods of early cancer detection, improved cancer patient care and new cancer drug development.

After a worldwide search, DePinho was appointed president of MD Anderson - just the fourth in the institution's 71-year history - on Sept. 1, 2011. Prior to this appointment, he served as the director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Cancer Institute and professor of medicine (genetics) at Harvard Medical School.

DePinho also held numerous faculty positions at the Albert Einstein College of Medicine. He received a bachelor's degree in biological sciences from Fordham College and his medical degree with distinction in microbiology and immunology from the Albert Einstein College of Medicine. He is a member of the Institute of Medicine and fellow of the American Academy of Arts and Sciences.

DePinho will be inducted into the NAS in April 2013.


'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Related medicine news :

1. David Anderson to discuss what model organisms can teach us about emotion
2. LodgeNet Healthcare Deploys Custom Education Solution for M. D. Anderson Cancer Center
3. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
4. Costly tests may not help detect bladder cancer recurrence, M. D. Anderson study finds
5. M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients
6. M. D. Anderson receives 4.5 million grant, largest ever for study of yoga and cancer
7. NACDS' Anderson Says Retailers and Suppliers' “Health and Wellness Renaissance” is Creating a “Historic, Watershed Moment”
8. Anderson & Kriger Takes Donations to Families Affected by Baja's Easter Earthquake
9. Peg Fields to receive MD Andersons highest nurse-oncologist honor
10. MD Anderson keeps No. 1 cancer ranking in US News & World Report annual survey
11. UT MD Anderson study finds women treated for breast cancer while pregnant have improved survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: